Search results for "Spar"

showing 10 items of 1739 documents

Freehand three-dimensional assessment of left ventricular volumes and ejection fraction with ultrasound contrast agent LK565

2005

Accurate assessment of left ventricular function by determining left ventricular volumes and ejection fraction is important in evaluating the prognoses of patients with heart failure. Two-dimensional (2D) echocardiography suffers from low correlation with reference methods like ventriculography. Three-dimensionally (3D) assessed data have been proved to have better conformity. Endocardial border delineation remains a problem, however, especially in patients with suboptimal recordings. Few data exist on 3D-echocardiographic volumetry with ultrasound contrast agents (UCAs). We evaluated the second-generation UCA LK565 for its boundary-tracing capacities in freehand 3D echocardiography in a ph…

AdultMalemedicine.medical_specialtyHeart VentriclesDiastoleContrast MediaImaging Three-DimensionalInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingSystoleEndocardiumAgedUltrasonographyHeart FailureAspartic AcidEjection fractionbusiness.industryUltrasoundStroke VolumeGeneral MedicineStroke volumeMiddle Agedmedicine.diseaseHeart failureCardiologyFeasibility StudiesEnd-diastolic volumeFemaleCardiology and Cardiovascular MedicinebusinessEuropean Journal of Echocardiography
researchProduct

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclero…

2003

Summary Lower levels of N-acetylaspartate (NAA), a marker of axonal damage, have been found in the normal-appearing white matter (NAWM) of relapsing-remitting multiple sclerosis (RRMS) patients with low physical disability. However, its relation to the clinical status of these patients remains unclear. We explored the association between NAA levels [normalized to creatine (Cr), NAA/Cr] and a cognitive feature that is not measured by the standard scales that address functional disability [e.g. Expanded Disability Scale Score (EDSS)] in early RRMS. Given that a considerable number of RRMS patients present attentional dysfunction early in the disease and assuming a functional-anatomical orient…

AdultMalemedicine.medical_specialtyMagnetic Resonance SpectroscopyAudiologyLateralization of brain functionDichotic Listening TestsCentral nervous system diseaseWhite matterDisability EvaluationMultiple Sclerosis Relapsing-RemittingmedicineHumansAttentionAnalysis of VarianceAspartic AcidDichotic listeningMultiple sclerosismedicine.diseaseAxonsmedicine.anatomical_structurenervous systemLinear ModelsLocus coeruleusFemaleLocus CoeruleusNeurology (clinical)Analysis of varianceCognition DisordersPsychologyNeuroscienceReticular activating systemBiomarkersBrain
researchProduct

Study of hypothalamic metabolism in cluster headache by proton MR spectroscopy

2006

The authors used 1H-MRS to investigate hypothalamic metabolism in 26 patients with cluster headache (CH) and 12 healthy subjects. Hypothalamic N-acetylaspartate/creatine was reduced in patients with CH vs controls (p < 0.01). Dividing the patients into episodic CH outside- and in-cluster periods and chronic CH, the hypothalamic N-acetylaspartate/creatine in all three subgroups of patients was reduced. The reduction of the neuronal marker N-acetylaspartate is consistent with hypothalamic neuronal dysfunction in patients with CH.

AdultMalemedicine.medical_specialtyMagnetic Resonance SpectroscopyHypothalamusCluster HeadacheCreatineCentral nervous system diseasechemistry.chemical_compoundParietal LobeInternal medicinemedicineHumansIn patientBRAINAgedCerebral CortexNeuronsAspartic AcidSPECTROSCOPYVascular diseasebusiness.industryCluster headacheproton MRMetabolismMiddle AgedCreatinemedicine.diseasehypothalamuDYSFUNCTIONProton mr spectroscopyEndocrinologychemistryHypothalamusAcute DiseaseChronic DiseaseFemaleOccipital LobeNeurology (clinical)ProtonsbusinessmetabolismBiomarkersNeurology
researchProduct

Treatment of cT1a Renal Tumours in Germany: A Nationwide Survey.

2015

&lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; To identify clinical parameters influencing German urologists treating cT1a renal tumours, we performed a nationwide survey among members of the German urological associations (DGU and BDU). &lt;b&gt;&lt;i&gt;Material and Methods:&lt;/i&gt;&lt;/b&gt; In spring 2012, DGU and BDU members were invited to complete our survey. For 8 cases and 3 index patients, participants were asked about their preferred treatment. Multivariate analyses were used to identify significant parameters leading the responders to favour radical nephrectomy (RN) over nephron sparing surgery (NSS) as well as active surveillance (AS) over invasive treatment. &lt;b&gt;&lt;i…

AdultMalemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentBiopsyUrology030232 urology & nephrologyRenal functionNationwide surveyKidneyNephrectomy03 medical and health sciencesImpaired renal function0302 clinical medicineInternal medicineGermanySurveys and QuestionnairesBiopsymedicineHumansAgedKidneymedicine.diagnostic_testbusiness.industryNephronsMiddle AgedNephrectomyKidney NeoplasmsSurgerymedicine.anatomical_structure030220 oncology & carcinogenesisMultivariate AnalysisFemaleNephron sparing surgerybusinessTomography X-Ray ComputedUrologia internationalis
researchProduct

Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis

1997

Lysosomal cathepsins D (CD), B (CB), and L (CL) serum levels were determined by immunoassays in patients with chronic (CHP) or acute (AP) pancreatitis and in patients with ductal pancreatic carcinoma (DPC) and correlated with some biological and clinical parameters of this tumor. CB serum concentrations significantly higher than those measured in healthy subjects (NS) were observed in CHP, AP, and DPC patients (p &lt; 0.01). However, no significant difference was noted among these groups. Increased CL serum levels were evident only in cancer patients compared to NS, AP, or CHP groups (p &lt; 0.05), while no difference was observed among these groups. Elevated CD serum values were observed i…

AdultMalemedicine.medical_specialtyPancreatic diseaseCA-19-9 AntigenEndocrinology Diabetes and MetabolismCathepsin LLysosomal proteinaseCathepsin DTumor markers.Cathepsin BEndocrinologyPancreatic cancerInternal medicineEndopeptidasesInternal MedicinemedicineCarcinomaAspartic Acid EndopeptidasesHumansAntigens Tumor-Associated CarbohydrateAgedAged 80 and overVHepatologybusiness.industryCarcinoma Ductal BreastCancerPancreatic cancerMiddle Agedmedicine.diseaseCathepsinsPancreatic NeoplasmsCysteine EndopeptidasesEndocrinologymedicine.anatomical_structurePancreatitisTumor progressionAdenocarcinomaPancreatitisFemalePancreasbusinessLysosomes
researchProduct

Level of agreement between physician and patient assessment of non-medical health factors.

2018

Background GPs need to consider assorted relevant non-medical factors, such as family or work situations or health insurance coverage, to determine appropriate patient care. If GPs' knowledge of these factors varies according to patients' social position, less advantaged patients might receive poorer care, resulting in the perpetuation of social inequalities in health. Objective To assess social disparities in GPs' knowledge of non-medical factors relevant to patient care. Methods Observational survey of GPs who supervise internships in the Paris metropolitan area. Each of the 52 enrolled GPs randomly selected 70 patients from their patient list. Their knowledge of five relevant factors (co…

AdultMalemedicine.medical_specialtyParisAttitude of Health PersonnelMEDLINE03 medical and health sciencesSocial support0302 clinical medicinePhysiciansSurveys and QuestionnairesMedicineSocial positionHumansSocial inequality030212 general & internal medicineAgedPhysician-Patient RelationsHealth economicsInsurance Healthbusiness.industry030503 health policy & servicesMultilevel modelSocial SupportHealth Status DisparitiesMiddle AgedSocioeconomic FactorsFamily medicineNeeds assessmentObservational studyFemalePerception0305 other medical scienceFamily PracticebusinessNeeds AssessmentFamily practice
researchProduct

Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.

2006

: Background/Aim: Liver steatosis (LS) has been variably associated with chronic hepatitis C (CHC) but whether it affects sustained virological response to antiviral treatment and by what mechanisms is a question still under debate, at least for some genotypes. The aim of this work was to assess the frequency of LS, its relationship with host and viral factors and to what extent it can influence the response to antiviral combination therapy with pegylated interferon (INF)+ribavirin in a group of patients with CHC from a single center. Patients: One hundred and twelve patients with histologically proven CHC were treated with Peg INF-α 2a 180 μg a week subcutaneously for 48 weeks plus ribavir…

AdultMalemedicine.medical_specialtyPathologyAgingCombination therapyGenotypeHepatitis C virusantiviral treatmentHepacivirusInterferon alpha-2Single Centermedicine.disease_causeGastroenterologyAntiviral AgentsSeverity of Illness IndexBody Mass IndexPolyethylene Glycolsliver steatosischemistry.chemical_compoundPegylated interferonInternal medicineGenotypeRibavirinmedicinechronic hepatitis CHumansAspartate AminotransferasesHepatologybusiness.industryRibavirinInterferon-alphaAlanine Transaminasegamma-GlutamyltransferaseHepatitis C ChronicMiddle Agedmedicine.diseaseRecombinant ProteinsFatty LiverTreatment OutcomechemistryLiverDrug Therapy CombinationFemaleSteatosisbusinessBody mass indexmedicine.drugLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Post-infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis.

2008

In post-infancy, multinucleated giant cell hepatitis is rare. Various conditions and diseases associated with post-infantile giant cell hepatitis have been described, but the pathogenesis remains unknown. In this paper we review the case reports of four patients (3 male, 1 female; aged 22 to 32 years) with primary sclerosing cholangitis and autoimmune hepatitis. The follow-up ranges from five to seven years. All patients showed cholestasis and repeated elevation of hepatic transaminases. Patients with viral infections, metabolic disorders and toxic influences were excluded. Histopathology of liver tissue in all four patients revealed giant cell formation with up to 20 nuclei in 20-70% of al…

AdultMalemedicine.medical_specialtyPathologyCirrhosisCholangitisAutoimmunityAutoimmune hepatitisGiant CellsPrimary sclerosing cholangitisHepatitisCholestasisAdrenal Cortex HormonesHLA AntigensmedicineHumansAspartate AminotransferasesAutoimmune diseaseHepatitisCholangiopancreatography Endoscopic RetrogradeCholestasisHepatologybusiness.industryHistocytochemistryUrsodeoxycholic AcidAlanine TransaminaseBilirubinmedicine.diseaseSerologyGiant cellHistopathologyFemalebusinessImmunosuppressive AgentsLiver
researchProduct

The cheating liver: imaging of focal steatosis and fatty sparing

2016

ABSTRACT: Focal steatosis and fatty sparing are a frequent finding in liver imaging, and can mimic solid lesions. Liver regional variations in the degree of fat accumulation can be related to vascular anomalies, metabolic disorders, use of certain drugs or coexistence of hepatic masses. CT and MRI are the modalities of choice for the noninvasive diagnosis of hepatic steatosis. Knowledge of CT and MRI appearance of focal steatosis and fatty sparing is crucial for an accurate diagnosis, and to rule-out other pathologic processes. This paper will review the CT and MRI techniques for the diagnosis of hepatic steatosis and the CT and MRI features of common and uncommon causes of focal steatosis …

AdultMalemedicine.medical_specialtyPathologyPrognosiComputed Tomography AngiographyAdipose tissuePredictive Value of Testliver030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFat accumulationPredictive Value of TestsRisk FactorsNon-alcoholic Fatty Liver DiseaseInternal medicinemedicineHumansFocal steatosiLiver imagingComputed tomography angiographyAgedintegumentary systemmedicine.diagnostic_testHepatologybusiness.industryRisk FactorFatty liverGastroenterologyMagnetic resonance imagingfatty sparingHepatologyMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingAdipose Tissue030220 oncology & carcinogenesisFemaleRadiologySteatosisbusinessCTMRIFatty Liver AlcoholicHuman
researchProduct

Blood laboratory findings in patients suffering from self-perceived electromagnetic hypersensitivity (EHS)

2009

Risks from electromagnetic devices are of considerable concern. Electrohypersensitive (EHS) persons attribute a variety of rather unspecific symptoms to exposure to electromagnetic fields. The pathophysiology of EHS is unknown and therapy remains a challenge. We hypothesized that some electrosensitive individuals are suffering from common somatic health problems. Toward this end we analysed clinical laboratory parameters including thyroid-stimulating hormone (TSH), alanine transaminase (ALT), aspartate transaminase (AST), creatinine, hemoglobine, hematocrit and c-reactive protein (CRP) in subjects suffering from EHS and in controls that are routinely used in clinical medicine to identify or…

AdultMalemedicine.medical_specialtyPhysiologyBiophysicsThyrotropinAspartate transaminaseHematocritElectromagnetic hypersensitivitychemistry.chemical_compoundElectromagnetic FieldsInternal medicineHypersensitivitymedicineHumansRadiology Nuclear Medicine and imagingIn patientAspartate AminotransferasesAgedInflammationCreatininebiologymedicine.diagnostic_testbusiness.industryLiver DiseasesAlanine TransaminaseAnemiaGeneral MedicineMiddle AgedThyroid DiseasesPathophysiologyC-Reactive ProteinEndocrinologychemistryAlanine transaminaseCreatininebiology.proteinFemalePerceptionmedicine.symptombusinessHormoneBioelectromagnetics
researchProduct